ASKB589 in Combination With CAPOX and PD-1 Inhibitors in Patients With Advanced, and Unresectable G/GEJ Cancer.
Clinical trial NCT05632939 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05632939
- Sponsor
- AskGene Pharma, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-21
- Primary completion
- 2025-10-31
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.